Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Respir Med
    May 2024
  1. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    >> Share

    April 2024
  2. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    >> Share

  3. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    >> Share

  4. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    >> Share

  5. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    >> Share

  6. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
    Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
    >> Share

  7. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
    Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
    Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
    >> Share

  8. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    >> Share

  9. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    >> Share

  10. LAI K, Sun D, Dai R, Samoro R, et al
    Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
    Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
    >> Share

  11. XU X, Yin J, Yang Y, Liu H, et al
    Advances in co-pathogenesis of the united airway diseases.
    Respir Med. 2024;225:107580.
    >> Share

    March 2024
  12. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
    Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
    >> Share

  13. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    >> Share

  14. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    >> Share

    February 2024
  15. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    >> Share

  16. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    >> Share

  17. FARZANDIPOUR M, Arani MH, Sharif R, Nabovati E, et al
    Improving asthma control and quality of life via a smartphone self-management app: A randomized controlled trial.
    Respir Med. 2024 Feb 5:107539. doi: 10.1016/j.rmed.2024.107539.
    >> Share

    January 2024
  18. ZHANG T, Xu L, Zhang Y, Zhen L, et al
    The diagnostic value of bronchial provocation testing combined with fractional exhaled nitric oxide (FeNO) in children with chest tightness-variant asthma (CTVA).
    Respir Med. 2024 Jan 27:107543. doi: 10.1016/j.rmed.2024.107543.
    >> Share

  19. PAPI A, Castro M, Corren J, Pavord ID, et al
    Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
    Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
    >> Share

  20. CHASE NM, Littlejohn M, Holweg CTJ, Millette LA, et al
    Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma.
    Respir Med. 2024 Jan 20:107537. doi: 10.1016/j.rmed.2024.107537.
    >> Share

  21. SIORA A, Vontetsianos A, Chynkiamis N, Anagnostopoulou C, et al
    Small airways in asthma: From inflammation and pathophysiology to treatment response.
    Respir Med. 2024 Jan 14:107532. doi: 10.1016/j.rmed.2024.107532.
    >> Share

  22. BACKMAN H, Lindmark SW, Hedman L, Kankaanranta H, et al
    The interplay between obesity and blood neutrophils in adult-onset asthma.
    Respir Med. 2024 Jan 10:107529. doi: 10.1016/j.rmed.2024.107529.
    >> Share

  23. BRESLAVSKY A, Al Qaied A, Tsenter P, Mukaseev N, et al
    Comparison of clinical remission criteria for severe asthma patients receiving biologic therapy.
    Respir Med. 2024 Jan 8:107528. doi: 10.1016/j.rmed.2024.107528.
    >> Share

  24. DELMAS MC, Pasquereau A, Renuy A, Benezet L, et al
    Electronic cigarette use and respiratory symptoms in the French population-based Constances cohort.
    Respir Med. 2024;221:107496.
    >> Share

    December 2023
  25. VISSER E, Ten Brinke A, Sizoo D, Pepels JJS, et al
    Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review.
    Respir Med. 2023;221:107504.
    >> Share

  26. DE-MIGUEL-DIEZ J, Gutierrez-Albaladejo N, Caballero-Segura FJ, Lopez-de-Andres A, et al
    Trends and sex differences in atrial fibrillation among patients hospitalized due to asthma: Insights from a nationwide population-based discharge database in Spain, 2016-2021.
    Respir Med. 2023;221:107508.
    >> Share

  27. MIR FAKHRAEI R, Lindberg E, Benediktsdottir B, Svanes C, et al
    Gastroesophageal reflux and snoring are related to asthma and respiratory symptoms: Results from a Nordic longitudinal population survey.
    Respir Med. 2023 Dec 13:107495. doi: 10.1016/j.rmed.2023.107495.
    >> Share

  28. SUN Y, Zhang Y, Bai W, Liu X, et al
    Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.
    Respir Med. 2023;220:107451.
    >> Share

  29. QUADFLIEG K, Machado A, de Lima FF, Dederen A, et al
    Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
    Respir Med. 2023;220:107437.
    >> Share

    November 2023
  30. FREELS L, Herman A, Lukas S, Chan AHY, et al
    Asthma control and associated risk factors among adults with current asthma: Findings from 2019 behavioral risk factor surveillance system asthma call-back survey.
    Respir Med. 2023 Nov 25:107479. doi: 10.1016/j.rmed.2023.107479.
    >> Share

  31. ROCHE N, Yorgancioglu A, Cruz AA, Garcia G, et al
    Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting beta(2)-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance a
    Respir Med. 2023 Nov 24:107478. doi: 10.1016/j.rmed.2023.107478.
    >> Share

  32. MATTILA T, Vasankari T, Herse F, Leskela RL, et al
    Contrasting healthcare costs of COPD and asthma in elderly.
    Respir Med. 2023 Nov 21:107477. doi: 10.1016/j.rmed.2023.107477.
    >> Share

  33. URDOVA V, Rogers L, Jesenak M, Seys SF, et al
    Real-life studies and registries of severe asthma: The advent of digital technology.
    Respir Med. 2023 Nov 3:107429. doi: 10.1016/j.rmed.2023.107429.
    >> Share

  34. MATERA MG, Rinaldi B, Ambrosio C, Cazzola M, et al
    Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?
    Respir Med. 2023;219:107439.
    >> Share

  35. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    >> Share

    October 2023
  36. RENNER A, Stoshikj S, Pohl W, Bal C, et al
    Characterization of Austrian severe asthma patients.
    Respir Med. 2023 Oct 10:107427. doi: 10.1016/j.rmed.2023.107427.
    >> Share

  37. HENRY C, Biardel S, Boucher M, Godbout K, et al
    Bronchial thermoplasty attenuates bronchodilator responsiveness.
    Respir Med. 2023;217:107340.
    >> Share

  38. AXELSSON M, Backman H, Nwaru BI, Stridsman C, et al
    Underdiagnosis and misclassification of COPD in Sweden - A Nordic Epilung study.
    Respir Med. 2023;217:107347.
    >> Share

    September 2023
  39. ROGERS L, Jesenak M, Bjermer L, Hanania NA, et al
    Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.
    Respir Med. 2023 Sep 28:107414. doi: 10.1016/j.rmed.2023.107414.
    >> Share

  40. WINSA-LINDMARK S, Stridsman C, Sahlin A, Hedman L, et al
    Severity of adult onset-asthma-a matter of blood neutrophils and severe obesity.
    Respir Med. 2023 Sep 26:107418. doi: 10.1016/j.rmed.2023.107418.
    >> Share

  41. KROES JA, Van Hal LHG, Van Dijk L, Zielhuis SW, et al
    The perceived waning of biologics in severe asthma.
    Respir Med. 2023 Sep 25:107416. doi: 10.1016/j.rmed.2023.107416.
    >> Share

    August 2023
  42. MASPERO JF, Shafazand S, Cole J, Pavord ID, et al
    Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
    Respir Med. 2023 Aug 31:107344. doi: 10.1016/j.rmed.2023.107344.
    >> Share

  43. COTTINI M, Bondi B, Bagnasco D, Braido F, et al
    Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control.
    Respir Med. 2023 Aug 16:107391. doi: 10.1016/j.rmed.2023.107391.
    >> Share

  44. ASSAF S, Stenberg H, Jesenak M, Tarasevych SP, et al
    Asthma in the era of COVID-19.
    Respir Med. 2023 Aug 9:107373. doi: 10.1016/j.rmed.2023.107373.
    >> Share

  45. DIERICK BJH, Achterbosch M, Eikholt AA, Been-Buck S, et al
    Electronic monitoring with a digital smart spacer to support personalized inhaler use education in patients with asthma: The randomized controlled OUTERSPACE trial.
    Respir Med. 2023 Aug 5:107376. doi: 10.1016/j.rmed.2023.107376.
    >> Share

  46. KAMINSKY DA, He J, Henderson R, Dixon AE, et al
    Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma.
    Respir Med. 2023 Aug 1:107375. doi: 10.1016/j.rmed.2023.107375.
    >> Share

    July 2023
  47. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting beta(2)-agonist plus short-acting beta(2) agonist reliever or maintenance and reliever therapy for asthma.
    Respir Med. 2023 Jul 29:107377. doi: 10.1016/j.rmed.2023.107377.
    >> Share

  48. DIAMANT Z, Jesenak M, Hanania NA, Heaney LG, et al
    EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.
    Respir Med. 2023 Jul 28:107361. doi: 10.1016/j.rmed.2023.107361.
    >> Share

  49. JESENAK M, Durdik P, Oppova D, Franova S, et al
    Dysfunctional mucociliary clearance in asthma and airway remodeling - New insights into an old topic.
    Respir Med. 2023 Jul 27:107372. doi: 10.1016/j.rmed.2023.107372.
    >> Share

  50. CHAN AHY, Tomlin A, Beyene K, Harrison J, et al
    Asthma exacerbations in New Zealand 2010-2019: A national population-based study.
    Respir Med. 2023;217:107365.
    >> Share

  51. PONTE EV, Rocha DGD, Guinossi RM, Bertoche L, et al
    Evaluating the relationship between the type of rescue medication and the adequacy of asthma maintenance therapy.
    Respir Med. 2023 Jul 18:107364. doi: 10.1016/j.rmed.2023.107364.
    >> Share

  52. DIAMANT Z, Seys SF, Rogers L, Hanania NA, et al
    Integrating innovations in asthma research into clinical practice.
    Respir Med. 2023;217:107345.
    >> Share

  53. BAYDUR A, Barbers R, May D
    Effect of bronchial thermoplasty on static and dynamic lung compliance and resistance in patients with severe persistent asthma.
    Respir Med. 2023 Jul 8:107341. doi: 10.1016/j.rmed.2023.107341.
    >> Share

  54. GEPHINE S, Fry S, Margoline E, Gicquello A, et al
    Home-based pulmonary rehabilitation for adults with severe asthma exposed to psychosocial chronic stressors.
    Respir Med. 2023 Jul 7:107349. doi: 10.1016/j.rmed.2023.107349.
    >> Share

  55. PORTACCI A, Iorillo I, Quaranta VN, Maselli L, et al
    Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience.
    Respir Med. 2023;217:107348.
    >> Share

    June 2023
  56. KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
    Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
    Respir Med. 2023 Jun 29:107334. doi: 10.1016/j.rmed.2023.107334.
    >> Share

  57. MOHAN A, Lugogo NL
    Mild asthma: Lessons learned and remaining questions.
    Respir Med. 2023 Jun 14:107326. doi: 10.1016/j.rmed.2023.107326.
    >> Share

  58. ADRISH M, Akuthota P
    Approach to non-type 2 asthma.
    Respir Med. 2023 Jun 10:107327. doi: 10.1016/j.rmed.2023.107327.
    >> Share

  59. NISHIYAMA H, Kanemitsu Y, Hara J, Fukumitsu K, et al
    Bronchial thermoplasty improves cough hypersensitivity and cough in severe asthmatics.
    Respir Med. 2023 Jun 10:107303. doi: 10.1016/j.rmed.2023.107303.
    >> Share

  60. PANETTIERI RA, Lugogo N, Moore WC, Chipps BE, et al
    Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
    Respir Med. 2023 Jun 6:107285. doi: 10.1016/j.rmed.2023.107285.
    >> Share

  61. STURESSON A, Hedman L, Stridsman C, Lindberg A, et al
    Obesity associates with increased all-cause and cardiovascular mortality in adults with asthma.
    Respir Med. 2023 Jun 4:107301. doi: 10.1016/j.rmed.2023.107301.
    >> Share

  62. SELBERG S, Karlsson Sundbaum J, Konradsen JR, Backman H, et al
    Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
    Respir Med. 2023;216:107308.
    >> Share

  63. KISIEL MA, Sedvall M, Malinovschi A, Franklin KA, et al
    Inflammatory bowel disease and asthma. Results from the RHINE study.
    Respir Med. 2023 Jun 2:107307. doi: 10.1016/j.rmed.2023.107307.
    >> Share

  64. ESTEBAN C, Anton-Ladislao A, Aramburu A, Chasco L, et al
    Change in physical activity related to admission for exacerbation in COPD patients.
    Respir Med. 2023;212:107236.
    >> Share

    May 2023
  65. BRUNN B, Hapfelmeier A, Jorres RA, Schultz K, et al
    Development of a diagnostic score using FeNO and symptoms to predict asthma.
    Respir Med. 2023 May 29:107299. doi: 10.1016/j.rmed.2023.107299.
    >> Share

  66. LIANG Y, Zhang J, Bai S, Du S, et al
    Short-term and long-term effects of cesarean section on asthma and wheezing: A cohort study and meta-analysis.
    Respir Med. 2023 May 29:107300. doi: 10.1016/j.rmed.2023.107300.
    >> Share

  67. FONG KY, Zhao JJ, Syn NL, Nair P, et al
    Comparing bronchial thermoplasty with biologicals for severe asthma: Systematic review and network meta-analysis.
    Respir Med. 2023 May 29:107302. doi: 10.1016/j.rmed.2023.107302.
    >> Share

  68. LOZANO-ESPINOSA M, Antolin-Amerigo D, Riera J, Gordo Vidal F, et al
    Extracorporeal membrane oxygenation (ECMO) and beyond in near fatal asthma: A comprehensive review.
    Respir Med. 2023;215:107246.
    >> Share

  69. KHAN S, Ouaalaya EH, Chauveau AD, Scherer E, et al
    Whispers of change in preschool asthma phenotypes: Findings in the French ELFE cohort.
    Respir Med. 2023 May 22:107263. doi: 10.1016/j.rmed.2023.107263.
    >> Share

  70. BOUSSO A, Chuffart C, Leroy M, Gicquello A, et al
    Severity and phenotypes of dyspnea in asthma: Impact of comorbidities.
    Respir Med. 2023 May 20:107276. doi: 10.1016/j.rmed.2023.107276.
    >> Share

  71. KHORASANI AM, Mohammadi B, Saghafi MR, Mohammadi S, et al
    The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.
    Respir Med. 2023 May 3:107260. doi: 10.1016/j.rmed.2023.107260.
    >> Share

  72. LAORDEN D, Zamarron E, Romero D, Dominguez-Ortega J, et al
    Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R.
    Respir Med. 2023;211:107216.
    >> Share

  73. BASHIR MBA, Basna R, Hedman L, Backman H, et al
    Interaction of smoking and social status on the risk of respiratory outcomes in a Swedish adult population: A Nordic Epilung study.
    Respir Med. 2023;211:107192.
    >> Share

    April 2023
  74. PRICE OJ, Simpson AJ
    Exercise and asthma - trigger or treatment?
    Respir Med. 2023;213:107247.
    >> Share

  75. GU W, Tian Z, Tian W, Song Y, et al
    Association of rest-activity circadian rhythm with chronic respiratory diseases, a cross-section survey from NHANES 2011-2014.
    Respir Med. 2023;209:107147.
    >> Share

    March 2023
  76. KISIEL MA, Arnfelt O, Lindberg E, Jogi O, et al
    Association between abdominal and general obesity and respiratory symptoms, asthma and COPD. Results from the RHINE study.
    Respir Med. 2023;211:107213.
    >> Share

  77. VAN DER BURG N, Tufvesson E
    Is asthma's heterogeneity too vast to use traditional phenotyping for modern biologic therapies?
    Respir Med. 2023 Mar 14:107211. doi: 10.1016/j.rmed.2023.107211.
    >> Share

  78. VAN ZYL-SMIT RN, Kerstjens HA, Maspero JF, Kostikas K, et al
    Efficacy of once-daily, single-inhaler, fixed-dose combination of mometasone/indacaterol/glycopyrronium in patients with asthma with or without persistent airflow limitation: Post hoc analysis from the IRIDIUM study.
    Respir Med. 2023 Mar 9:107172. doi: 10.1016/j.rmed.2023.107172.
    >> Share

    February 2023
  79. BAKAKOS P, Tryfon S, Palamidas A, Mathioudakis N, et al
    Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
    Respir Med. 2023;210:107170.
    >> Share

  80. ERJEFALT JS
    Anatomical and histopathological approaches to asthma phenotyping.
    Respir Med. 2023 Feb 21:107168. doi: 10.1016/j.rmed.2023.107168.
    >> Share

  81. COTTINI M, Lombardi C, Comberiati P, Landi M, et al
    Small airway dysfunction in asthmatic patients treated with as-needed SABA monotherapy: A perfect storm.
    Respir Med. 2023 Feb 14:107154. doi: 10.1016/j.rmed.2023.107154.
    >> Share

  82. SORENSEN KG, Oymar K, Jonsson G, Dalen I, et al
    Are BMI and adipokines associated with asthma, atopy and lung function in young adults previously hospitalized for bronchiolitis?
    Respir Med. 2023 Feb 6:107149. doi: 10.1016/j.rmed.2023.107149.
    >> Share

  83. DESORMEAU B, Smyrnova A, Drouin O, Ducharme FM, et al
    Oscillometry to support clinical assessment in asthmatic preschoolers: Real-life impact.
    Respir Med. 2023 Feb 6:107148. doi: 10.1016/j.rmed.2023.107148.
    >> Share

  84. HILVERING B, Koenderman L
    Quality over quantity; eosinophil activation status will deepen the insight into eosinophilic diseases.
    Respir Med. 2023;207:107094.
    >> Share

    January 2023
  85. DIAMANT Z, van Maaren M, Muraro A, Jesenak M, et al
    Allergen immunotherapy for allergic asthma - The future seems bright.
    Respir Med. 2023 Jan 23:107125. doi: 10.1016/j.rmed.2023.107125.
    >> Share

  86. POMPE E, Kwee AK, Tejwani V, Siddharthan T, et al
    Imaging-derived biomarkers in Asthma: Current status and future perspectives.
    Respir Med. 2023 Jan 23:107130. doi: 10.1016/j.rmed.2023.107130.
    >> Share

  87. AL-SHUWELI S, Landt E, Ellervik C, Poulsen HE, et al
    Risk of asthma in offspring of asthmatic fathers versus mothers: A population-based study of 21,000 individuals in Denmark.
    Respir Med. 2023;207:107116.
    >> Share

  88. MACNEIL A, Li G, Jiang Y, de Groh M, et al
    Incident and recurrent depression among older adults with asthma during the COVID-19 pandemic: Findings from the Canadian Longitudinal Study on Aging.
    Respir Med. 2023 Jan 11:107003. doi: 10.1016/j.rmed.2022.107003.
    >> Share

  89. LOSOL P, Sokolowska M, Chang YS
    Interactions between microbiome and underlying mechanisms in asthma.
    Respir Med. 2023 Jan 11:107118. doi: 10.1016/j.rmed.2023.107118.
    >> Share

  90. LIU Y, Li P, Jiang T, Li Y, et al
    Epidermal growth factor receptor in asthma: A promising therapeutic target?
    Respir Med. 2023;207:107117.
    >> Share

    December 2022
  91. MATTILA T, Vasankari T, Kauppi P, Mazur W, et al
    Mortality of asthma, COPD, and asthma-COPD overlap during an 18-year follow up.
    Respir Med. 2022 Dec 31:107112. doi: 10.1016/j.rmed.2022.107112.
    >> Share

  92. THEODORO EE, Rocha DGD, Bertolino JR, Guinossi RM, et al
    Evaluating the effect of antidepressants on the relationship between depression and asthma.
    Respir Med. 2022;207:107099.
    >> Share

  93. LOUIS G, Schleich F, Louis R, Guillaume M, et al
    How respiratory symptoms impact asthma-related quality of life in mild asthmatics.
    Respir Med. 2022;207:107098.
    >> Share

  94. RENNER A, Marth K, Breyer-Kohansal R, Pohl W, et al
    Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria.
    Respir Med. 2022;207:107097.
    >> Share

  95. LI J, Price KR, Weeda ER, Garner SS, et al
    Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
    Respir Med. 2022;207:107096.
    >> Share

  96. LAORDEN D, Dominguez-Ortega J, Carpio C, Barranco P, et al
    Long COVID outcomes in an asthmatic cohort and its implications for asthma control.
    Respir Med. 2022 Dec 16:107092. doi: 10.1016/j.rmed.2022.107092.
    >> Share

  97. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
    Association of serum CC16 levels with eosinophilic inflammation and respiratory dysfunction in severe asthma.
    Respir Med. 2022;206:107089.
    >> Share

  98. ROTHE T, von Garnier C, Bridevaux PO, Charbonnier F, et al
    The clinical features of asthma exacerbations in early-onset and eosinophilic late-onset asthma may differ significantly.
    Respir Med. 2022;206:107067.
    >> Share

    November 2022
  99. THELEN JC, van Zelst CM, van Brummelen SE, Rauh S, et al
    Efficacy and safety of dupilumab as add-on therapy for patients with severe asthma: A real-world Dutch cohort study.
    Respir Med. 2022;206:107058.
    >> Share

  100. ROCHE N, Nadif R, Fabry-Vendrand C, Pillot L, et al
    Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.
    Respir Med. 2022;206:107057.
    >> Share

  101. PLEASANTS RA, Chan AH, Mosnaim G, Costello RW, et al
    Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease.
    Respir Med. 2022;205:107038.
    >> Share

  102. SANSORES RH, Paulin-Prado P, Robles-Hernandez R, Montiel-Lopez F, et al
    Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
    Respir Med. 2022;204:107010.
    >> Share

    October 2022
  103. MAIO S, Murgia N, Tagliaferro S, Angino A, et al
    The Italian severe/uncontrolled asthma registry (RItA): A 12-month clinical follow-up.
    Respir Med. 2022;205:107030.
    >> Share

  104. VAN DER PALEN J, Slade D, Rehal S, Verma M, et al
    A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
    Respir Med. 2022;205:107031.
    >> Share

  105. RYAN D, Keighley A, Jackson T
    Patient perspectives in asthma: Listening to and learning from a new paradigm in translational research.
    Respir Med. 2022;205:107013.
    >> Share

  106. CHAN KC, Au CT, Wong E, Chook P, et al
    Inferior endothelial function improved following optimisation of asthma control in children.
    Respir Med. 2022;204:107024.
    >> Share

  107. TOOBA R, Wu TD
    Obesity and asthma: A focused review.
    Respir Med. 2022;204:107012.
    >> Share

  108. CABALLERO-SEGURA FJ, Lopez-de-Andres A, Jimenez-Garcia R, de Miguel-Yanes JM, et al
    Trends in asthma hospitalizations among adults in Spain: Analysis of hospital discharge data from 2011 to 2020.
    Respir Med. 2022;204:107009.
    >> Share

  109. GHOSH S, Rihan M, Ahmed S, Pande AH, et al
    Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective.
    Respir Med. 2022;204:107007.
    >> Share

    September 2022
  110. MANEECHOTESUWAN K, Singh D, Fritscher LG, Dursunoglu N, et al
    Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis.
    Respir Med. 2022;203:106993.
    >> Share

  111. TRAN C, Singh GV, Haider E, Boylan C, et al
    Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study.
    Respir Med. 2022;202:106982.
    >> Share

  112. ROCHE N, Aggarwal B, Boucot I, Mittal L, et al
    The impact of inhaler technique on clinical outcomes in adolescents and adults with asthma: A systematic review.
    Respir Med. 2022;202:106949.
    >> Share

    August 2022
  113. BOURDIN A, Virchow JC, Papi A, Lugogo NL, et al
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
    Respir Med. 2022;202:106938.
    >> Share

  114. TAJIRI S, Kondo T, Tanigaki T, Hibino M, et al
    Daily inhaled flow profiles and drug release from dry powder inhalers in patients with bronchial asthma.
    Respir Med. 2022;201:106950.
    >> Share

  115. CHAPMAN KR, Canonica GW, Lavoie KL, Nenasheva N, et al
    Patients' and physicians' perspectives on the burden and management of asthma: Results from the APPaRENT 2 study.
    Respir Med. 2022;201:106948.
    >> Share

  116. CANONICA GW, Spanevello A, de Llano LP, Domingo Ribas C, et al
    Is asthma control more than just an absence of symptoms? An expert consensus statement.
    Respir Med. 2022;202:106942.
    >> Share

  117. TRELA KC, Zajac P, Zhu M, Press VG, et al
    Health literacy and type of education intervention predicting post-education metered-dose inhaler misuse.
    Respir Med. 2022;200:106930.
    >> Share

    July 2022
  118. ORLOVIC M, Magni T, Lukyanov V, Guerra I, et al
    Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England.
    Respir Med. 2022;201:106934.
    >> Share

  119. LI M, Wen Ma Z, Jun Deng S, Oliver BG, et al
    Development and validation of a noninvasive prediction model for identifying eosinophilic asthma.
    Respir Med. 2022;201:106935.
    >> Share

  120. HENRY SL, Moore LE, Brotto AR, Rowland S, et al
    Systemic vascular health is compromised in both confirmed and unconfirmed asthma.
    Respir Med. 2022;200:106932.
    >> Share

  121. ALHABEEB FF, Whitmore GA, Vandemheen KL, FitzGerald JM, et al
    Disease burden in individuals with symptomatic undiagnosed asthma or COPD.
    Respir Med. 2022;200:106917.
    >> Share

    June 2022
  122. PATELLA V, Pelaia C, Zunno R, Pelaia G, et al
    Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemic.
    Respir Med. 2022;200:106916.
    >> Share

  123. LIU L, Zhang X, Zhang L, Liu Y, et al
    Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: A prospective cohort study.
    Respir Med. 2022;200:106924.
    >> Share

  124. HUGHES R, Rapsomaniki E, Janson C, Keen C, et al
    Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study.
    Respir Med. 2022;200:106921.
    >> Share

  125. CAZZOLA M, Braido F, Calzetta L, Matera MG, et al
    The 5T approach in asthma: Triple Therapy Targeting Treatable Traits.
    Respir Med. 2022;200:106915.
    >> Share

  126. LEONARD SI, Turi ER, Powell JS, Usseglio J, et al
    Associations of asthma self-management and mental health in adolescents: A scoping review.
    Respir Med. 2022;200:106897.
    >> Share

    May 2022
  127. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    >> Share

  128. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    >> Share

  129. JIAO T, Schnitzer ME, Forget A, Blais L, et al
    Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
    Respir Med. 2022;198:106866.
    >> Share

  130. GOLAM SM, Janson C, Beasley R, FitzGerald JM, et al
    The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
    Respir Med. 2022;200:106863.
    >> Share

    March 2022
  131. KORN S, Milger K, Skowasch D, Timmermann H, et al
    Corrigendum to "The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control" [Respir. Med. 195 (2022) 106793].
    Respir Med. 2022;196:106827.
    >> Share

    February 2022
  132. KORN S, Milger K, Skowasch D, Timmermann H, et al
    The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
    Respir Med. 2022;195:106793.
    >> Share

  133. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
    Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
    Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
    >> Share

  134. AL-AHMAD M, Webb D
    A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
    Respir Med. 2022;194:106771.
    >> Share

    January 2022
  135. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
    Mental health in patients with asthma: A population-based case-control study.
    Respir Med. 2022;193:106758.
    >> Share

  136. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
    Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
    Respir Med. 2022;193:106757.
    >> Share

  137. BOURDIN A, Molinari N
    Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
    Respir Med. 2022;191:105999.
    >> Share

  138. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
    Respir Med. 2022;191:106088.
    >> Share

  139. MARTIN N, Papi A, Bratton DJ, Chan R, et al
    Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
    Respir Med. 2022;191:106065.
    >> Share

  140. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
    Respir Med. 2022;191:105991.
    >> Share

  141. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2022;191:106106.
    >> Share

    December 2021
  142. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
    Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
    Respir Med. 2021;191:106724.
    >> Share

  143. PENG J, Wu F, Tian H, Yang H, et al
    Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
    Respir Med. 2021;190:106681.
    >> Share

    November 2021
  144. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    >> Share

  145. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
    Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
    Respir Med. 2021;188:106621.
    >> Share

    October 2021
  146. CZIRA A, Turner M, Martin A, Hinds D, et al
    A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
    Respir Med. 2021;191:106670.
    >> Share

  147. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    >> Share

  148. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
    Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
    Respir Med. 2021;187:106595.
    >> Share

  149. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
    Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
    Respir Med. 2021;187:106572.
    >> Share

  150. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
    Risk factors for irreversible airway obstruction after infant bronchiolitis.
    Respir Med. 2021;187:106545.
    >> Share

    June 2021
  151. AL-QEREM WA, Jarab AS
    Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
    Respir Med. 2021;182:106397.
    >> Share

    May 2021
  152. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
    Sedentary time in people with obstructive airway diseases.
    Respir Med. 2021;181:106367.
    >> Share

    April 2021
  153. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    >> Share

    January 2021
  154. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    >> Share

  155. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016